BIAF

NASD bioAffinity Technologies, Inc.

Oct 29, 2026 · 8:06 AM ET LAST TRADE Market Closed

$3.12 ↓ -0.02 (-0.68%) Trading Down from the previous close of $3.14

YTD change: +164.29%
vs 20-day SMA: -26.96%
vs 200-day SMA: +16.62%

Price ranges

Previous day

$2.84 $3.16

open $2.95 close $3.14

+$0.19 (+6.44%)

Today

$0.00 $0.00

$3.12

Past week

$2.66 $3.73

from $3.57 now $3.12

-$0.45 (-12.64%)

Past month

$2.66 $9.38

from $6.56 now $3.12

-$3.44 (-52.46%)

This year

$0.33 $20.35

from $1.18 now $3.12

+$1.94 (+164.29%)

Price & Performance

+0.71 (+29.22%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 99.3% away from all-time highs of $466.50
BIAF is up 164% since the beginning of the year
BIAF is up 26% over the past 12 months
BIAF is down 52% over the past 1 month
6% of all BIAF investors are betting against BIAF

BIAF reads not so good: price sits above one of the two key moving averages, the 12-month move is +26.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-9.6

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $99.4K

Beta -4.04

Balance sheet & scale

IncomeN/A

Revenue$5.9M

Cash$2.4M

Debt$1.4K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $5.6M

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Competitor comparison

Ticker	Company	Price	Change
NTRA	Natera, Inc.	$424.42	+3.31%
GH	Guardant Health, Inc.	$182.59	+2.54%
NEOG	Neogen Corp	$12.12	-2.81%
WGS	GeneDx Holdings Corp. Class A	$64.69	+3.11%
ACHV	Achieve Life Sciences, Inc.	$6.85	-1.15%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.